Biggest News Aggregation in the World

Improper Orange Book News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Improper Orange Book. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Improper Orange Book Today - Breaking & Trending Today

Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca - AstraZeneca (NASDAQ:AZN), Amphastar Pharma (NASDAQ:AMPH)

Published: May 1, 2024

The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, and COPD medications. This initiative combats tactics hindering generic competition.

Source: benzinga.com

FTC's 100-Patent Orange Book Challenge Creates Uncertainty for Pharma Patent Listings

Published: November 9, 2023

On October 7, the Federal Trade Commission (FTC) sent letters to 10 pharmaceutical companies notifying them of the agency’s intent to challenge allegedly improper patent listings in the U.S. Food and Drug Administration’s (FDA) Orange Book.

Source: ipwatchdog.com